VNRX – volitionrx limited (US:NASDAQ)
Stock Stats
News
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
VolitionRx (NYSE:VNRX) had its "hold" rating reaffirmed by analysts at Maxim Group.
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use [Yahoo! Finance]
Form 4 VOLITIONRX LTD For: Nov 17 Filed by: Reynolds Cameron John
Form SCHEDULE 13G/A VOLITIONRX LTD Filed by: ARMISTICE CAPITAL, LLC
Form 8-K/A VOLITIONRX LTD For: Nov 07
Form 8-K VOLITIONRX LTD For: Nov 07
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Plummer Nicholas
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.